United Therapeutics Corporation
United Therapeutics Corporation (UTHR) — Form 144: Proposed sale of shares
AI-generated summary
Officer PAUL MAHON proposed to sell 8,300 shares of Common stock with an aggregate market value of $4,517,709.09 through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares were acquired via a stock option exercise on October 15, 2026. The proposed sale is associated with a trading plan adopted on August 11, 2025.
Key facts
- Seller
- PAUL MAHON
- Relationship
- Officer
- Shares to sell
- 8,300
- Market value
- $4,517,709.09
- Approximate sale date
- Oct 15, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Oct 15, 2026 · Stock Option Exercise
Rule 10b5-1 plan · adopted Aug 11, 2025
More UTHR filings
- 4
Filed Nov 9, 2026
- 144
Filed Nov 9, 2026
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 4
Filed Nov 5, 2026
- 4
Filed Nov 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.